Hypertension as cardiovascular risk factor in chronic kidney disease

M Burnier, A Damianaki - Circulation research, 2023 - Am Heart Assoc
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …

Circadian rhythm, clock genes, and hypertension: recent advances in hypertension

HM Costello, ML Gumz - Hypertension, 2021 - Am Heart Assoc
Accumulating evidence suggests that the molecular circadian clock is crucial in blood
pressure (BP) control. Circadian rhythms are controlled by the central clock, which resides in …

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

RC Hermida, JJ Crespo… - European heart …, 2020 - academic.oup.com
Abstract Aims The Hygia Chronotherapy Trial, conducted within the clinical primary care
setting, was designed to test whether bedtime in comparison to usual upon awakening …

[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension

G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

European Society of Hypertension position paper on ambulatory blood pressure monitoring

E O'Brien, G Parati, G Stergiou, R Asmar… - Journal of …, 2013 - journals.lww.com
Ambulatory blood pressure monitoring (ABPM) is being used increasingly in both clinical
practice and hypertension research. Although there are many guidelines that emphasize the …

CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies

AB Reiss, N Miyawaki, J Moon, LJ Kasselman… - Atherosclerosis, 2018 - Elsevier
Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD)
characterized by disruption of normal mineral homeostasis within the body. One or more of …

Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage

PE Drawz, AB Alper, AH Anderson… - Clinical Journal of the …, 2016 - journals.lww.com
Results The percentages of participants with controlled BP, white-coat, masked, and
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …

Management of hypertension in CKD: beyond the guidelines

E Judd, DA Calhoun - Advances in chronic kidney disease, 2015 - Elsevier
Hypertension (HTN) and CKD are closely associated with an intermingled cause and effect
relationship. Blood pressure (BP) typically rises with declines in kidney function, and …

[HTML][HTML] Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical …

D Banerjee, P Winocour, TA Chowdhury, P De… - BMC nephrology, 2022 - Springer
People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney
disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor …

CKiD (CKD in children) prospective cohort study: a review of current findings

CJ Wong, M Moxey-Mims, J Jerry-Fluker… - American Journal of …, 2012 - Elsevier
Chronic kidney disease (CKD) is a life-long condition associated with substantial morbidity
and premature death due to complications from a progressive decrease in kidney function …